Evidence map›Paper›PMID 31843020›Full record

ReviewRetrovirology2019

STLV-1 as a model for studying HTLV-1 infection.

Brice Jégado, Fatah Kashanchi, Hélène Dutartre, Renaud Mahieux

Open access · goldAbstract readReview
In one paragraph

Review in Retrovirology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Novel approaches for HTLV-1 therapy: innovative applications of CRISPR-Cas9.Revista do Instituto de Medicina Tropical de Sao Paulo · 2024
    Review
  8. Mouse Models for HTLV-1 Infection and Adult T Cell Leukemia.International journal of molecular sciences · 2023
    Review
  9. Review
  10. Precise excision of HTLV-1 provirus with a designer-recombinase.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Tuning Rex rules HTLV-1 pathogenesis.Frontiers in immunology · 2022
    Review
  16. Review
  17. Review
  18. Review
  19. Human T-cell Leukemia Virus Type 1 andPathogens (Basel, Switzerland) · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Brice JégadoInternational Center for Research in Infectiology, Retroviral Oncogenesis Laboratory, INSERM U1111 - Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Lyon, Fondation pour la Recherche Médicale, Labex Ecofect, Lyon, France.
Fatah KashanchiLaboratory of Molecular Virology, George Mason University, Manassas, VA, USA.
Hélène DutartreInternational Center for Research in Infectiology, Retroviral Oncogenesis Laboratory, INSERM U1111 - Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Lyon, Fondation pour la Recherche Médicale, Labex Ecofect, Lyon, France.
Renaud MahieuxInternational Center for Research in Infectiology, Retroviral Oncogenesis Laboratory, INSERM U1111 - Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Lyon, Fondation pour la Recherche Médicale, Labex Ecofect, Lyon, France. renaud.mahieux@ens-lyon.fr.ORCID 0000-0002-5129-6804
Université Claude Bernard Lyon 1 · FRGeorge Mason University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Few years after HTLV-1 identification and isolation in humans, STLV-1, its simian counterpart, was discovered. It then became clear that STLV-1 is present almost in all simian species. Subsequent molecular epidemiology studies demonstrated that, apart from HTLV-1 subtype A, all human subtypes have a simian homolog. As HTLV-1, STLV-1 is the etiological agent of ATL, while no case of TSP/HAM has been described. Given its similarities with HTLV-1, STLV-1 represents a unique tool used for performing clinical studies, vaccine studies as well as basic science.

Indexed as

AnimalsDeltaretrovirus InfectionsDisease Models, AnimalFemaleHTLV-I InfectionsHumansHuman T-lymphotropic virus 1MalePhylogenyPrimatesSimian T-lymphotropic virus 1Animal modelATLHTLV-1Interspecies transmissionPrevalenceSTLV-1Therapy

Identifiers

PMID31843020
PMCPMC6915939
OpenAlexW2996363759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.